Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication March 12, 2009
- Accepted for publication July 10, 2009
- Published online September 29, 2009.
Article Versions
- previous version (September 16, 2009 - 06:38).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2009 by Society of Nuclear Medicine
Author Information
- Michael S. Hofman 1–3 ,
- Nigel C. Smeeton 4 ,
- Sheila C. Rankin 1 , 2 ,
- Tom Nunan 1 , 2 and
- Michael J. O'Doherty 1 , 2
- 1PET Imaging Centre, Kings College London, London, United Kingdom; 2Division of Imaging, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom; 3Centre for Molecular Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia; and 4Division of Health and Social Care Research, King's College London, London, United Kingdom
- For correspondence or reprints contact: Michael S. Hofman, Centre for Molecular Imaging, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St., Melbourne 8006, Australia. E-mail: nucmedpet{at}drhofman.com
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Interobserver Agreement of Interim and End-of-Treatment 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma: Impact on Clinical Practice and Trials
- In Newly Diagnosed Diffuse Large B-Cell Lymphoma, Determination of Bone Marrow Involvement with 18F-FDG PET/CT Provides Better Diagnostic Performance and Prognostic Stratification Than Does Biopsy
- PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement